These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23242163)

  • 1. Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease.
    Kwong GA; von Maltzahn G; Murugappan G; Abudayyeh O; Mo S; Papayannopoulos IA; Sverdlov DY; Liu SB; Warren AD; Popov Y; Schuppan D; Bhatia SN
    Nat Biotechnol; 2013 Jan; 31(1):63-70. PubMed ID: 23242163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics.
    Warren AD; Kwong GA; Wood DK; Lin KY; Bhatia SN
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3671-6. PubMed ID: 24567404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Penetrating Hierarchically Structured Nanomarker for Imaging-Guided Urinary Monitoring of Cancer.
    Zhang XJ; Hu LY; Hu Y; Yang XT; Tang YY; Tang YY; Li S; Zhu D
    ACS Sens; 2020 Jun; 5(6):1567-1572. PubMed ID: 32456420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-encoded, synthetic biomarkers and multiplexed urinary monitoring: new frontiers in disease monitoring.
    Tempst P
    Clin Chem; 2013 Dec; 59(12):1694-5. PubMed ID: 23860599
    [No Abstract]   [Full Text] [Related]  

  • 5. Early urinary candidate biomarker discovery in a rat thioacetamide-induced liver fibrosis model.
    Zhang F; Ni Y; Yuan Y; Yin W; Gao Y
    Sci China Life Sci; 2018 Nov; 61(11):1369-1381. PubMed ID: 29961236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.
    Lin KY; Kwong GA; Warren AD; Wood DK; Bhatia SN
    ACS Nano; 2013 Oct; 7(10):9001-9. PubMed ID: 24015809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis-A multicentre study.
    Bannaga AS; Metzger J; Kyrou I; Voigtländer T; Book T; Melgarejo J; Latosinska A; Pejchinovski M; Staessen JA; Mischak H; Manns MP; Arasaradnam RP
    EBioMedicine; 2020 Dec; 62():103083. PubMed ID: 33160210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.
    Wu T; Fu Y; Brekken D; Yan M; Zhou XJ; Vanarsa K; Deljavan N; Ahn C; Putterman C; Mohan C
    J Immunol; 2010 Feb; 184(4):2183-93. PubMed ID: 20065116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Complete and Versatile Protocol: Decoration of Cell-Derived Matrices with Mass-Encoded Peptides for Multiplexed Protease Activity Detection.
    Dodt K; Driessen MD; Lamer S; Schlosser A; Lühmann T; Meinel L
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6598-6617. PubMed ID: 33320595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.
    Holt BA; Mac QD; Kwong GA
    J Vis Exp; 2018 Jul; (137):. PubMed ID: 30059042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
    Chen YT; Chen HW; Domanski D; Smith DS; Liang KH; Wu CC; Chen CL; Chung T; Chen MC; Chang YS; Parker CE; Borchers CH; Yu JS
    J Proteomics; 2012 Jun; 75(12):3529-45. PubMed ID: 22236518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis.
    von zur Muhlen C; Schiffer E; Sackmann C; Zürbig P; Neudorfer I; Zirlik A; Htun N; Iphöfer A; Jänsch L; Mischak H; Bode C; Chen YC; Peter K
    Mol Cell Proteomics; 2012 Jul; 11(7):M111.013847. PubMed ID: 22371488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics combined with pattern recognition and bioinformatics analysis methods for the development of pharmacodynamic biomarkers on liver fibrosis.
    Fang J; Wang L; Wang Y; Qiu M; Zhang Y
    Mol Biosyst; 2017 Jul; 13(8):1575-1583. PubMed ID: 28671700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The coding according molecular mass of synthetic biomarkers under comprehensive testing of urine components: horizons of disease monitoring].
    Tempst P
    Klin Lab Diagn; 2014 Nov; 59(11):4-5. PubMed ID: 25850235
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive diagnostic of periprosthetic joint infection by urinary peptide markers: A preliminary study.
    Omar M; Windhagen H; Krettek C; Ettinger M
    J Orthop Res; 2021 Feb; 39(2):339-347. PubMed ID: 33179279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
    Manna SK; Thompson MD; Gonzalez FJ
    Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.
    Warren AD; Gaylord ST; Ngan KC; Dumont Milutinovic M; Kwong GA; Bhatia SN; Walt DR
    J Am Chem Soc; 2014 Oct; 136(39):13709-14. PubMed ID: 25198059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts.
    Dudani JS; Buss CG; Akana RTK; Kwong GA; Bhatia SN
    Adv Funct Mater; 2016 May; 26(17):2919-2928. PubMed ID: 29706854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.